Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase  3, randomized, double-blind, placebo-controlled trial

Despite high disease burden, systemic treatment options for patients with atopic hand and/or foot dermatitis (H/F AD) are limited.

Source: Journal of the American Academy of Dermatology - January 29, 2024 Category: Dermatology Authors: Eric L. Simpson, Jonathan I. Silverberg, Margitta Worm, Golara Honari, Koji Masuda, Ewa Sygu ła, Marie L.A. Schuttelaar, Eric Mortensen, Elizabeth Laws, Bolanle Akinlade, Naimish Patel, Jennifer Maloney, Heather Paleczny, Dimittri Delevry, Jing Xiao, Ari Tags: Original article Source Type: research